TB and M/XDR-TB infection control in European TB reference centres: The Achilles' heel?

European Respiratory Journal

Volumn 38, Issue 5, 2011, Pages 1221-1223

  Sotgiu, G ^a   D'Ambrosio, L ^b   Centis, R ^b   Bothamley, G ^e   Cirillo, D M ^c   De Lorenzo, S ^d   Guenther, G ^f   Kliiman, K ^h   Muetterlein, R ^g   Spinu, V ⁱ   Villar, M ^j   Zellweger, J P ^k   Sandgren, A ^l   Huitric, E ^l   Lange, C ^f   Manissero, D ^l   Migliori, G B ^b  

^a UNIVERSITY OF SASSARI   (Italy)

^b WORLD HEALTH ORGANIZATION   (Switzerland)

^c SAN RAFFAELE HOSPITAL   (Italy)

^d Reference Hospital for MDR and HIV TB   (Italy)

^e HOMERTON UNIVERSITY HOSPITAL   (United Kingdom)

^f RESEARCH CENTER BORSTEL   (Germany)

^g Parsberg Hospital   (Germany)

^h UNIVERSITY OF TARTU   (Estonia)

ⁱ MDR TB Centre   (Romania)

^j General Directorate of Health in Lisbon and Lung Diseases Centre of Venda Nova   (Portugal)

^k UNIVERSITY OF LAUSANNE   (Switzerland)

^l EUROPEAN CENTRE FOR DISEASE PREVENTION AND CONTROL ECDC   (Sweden)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; CAPREOMYCIN; ISONIAZID; KANAMYCIN; RIFAMPICIN;

BACTERIAL TRANSMISSION; EUROPEAN UNION; EXTENSIVELY DRUG RESISTANT TUBERCULOSIS; HOSPITAL INFECTION; INFECTION PREVENTION; LETTER; MULTIDRUG RESISTANT TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS; NEGATIVE PRESSURE VENTILATION; NONHUMAN; PRIORITY JOURNAL; PROTECTIVE EQUIPMENT; TUBERCULOSIS CONTROL;

DATA COLLECTION; EUROPE; EUROPEAN UNION; EXTENSIVELY DRUG-RESISTANT TUBERCULOSIS; HEALTH FACILITIES; HUMANS; TUBERCULOSIS, MULTIDRUG-RESISTANT;

EID: 80051511348     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00029311     Document Type: Letter

References (12)

1. World Health Organization. Multidrug and Extensively Drug- Resistant TB (M/XDR-TB). 2010 Global Report on Surveillance and Response. WHO/HTM/TB/2010.3. Geneva, World Health Organization, 2010.
2. Sotgiu G, Ferrara G, Matteelli A, et al. Epidemiology and clinical management of XDR-TB: a systematic review by TBNET. Eur Respir J 2009; 33: 871-881.
3. Migliori GB, Loddenkemper R, Blasi F, et al. 125 years after Robert Koch's discovery of the tubercle bacillus - the new XDR-TB threat. Is "science" enough to tackle the epidemic? Eur Respir J 2007; 29: 423-427. (Pubitemid 46372084)
4. Migliori GB, Besozzi G, Girardi E, et al. Clinical and operational value of the extensively drug-resistant tuberculosis definition. Eur Respir J 2007; 30: 623-626. (Pubitemid 351194820)
5. Migliori GB, Ortmann J, Girardi E, et al. Extensively drug-resistant tuberculosis, Italy and Germany. Emerg Infect Dis 2007; 13: 780-782. (Pubitemid 46698749)
6. World Health Organization. Extensively drug-resistant tuberculosis (XDR-TB): recommendations for prevention and control. Wkly Epidemiol Rec 2006; 81: 430-432.
7. Raviglione MC, Uplekar MW. WHO's new Stop TB Strategy. Lancet 2006; 367: 952-955.
8. World Health Organization. WHO Policy on Infection Control in Health-Care Facilities, Congregate Settings and Households. WHO/HTM/TB/2009.419. Geneva, World Health Organization, 2009.
9. Sotgiu G, Centis R, D'Ambrosio L, et al. Development of a standardised tool to survey MDR-/XDR-TB case management in Europe. Eur Respir J 2010; 36: 208-211.
10. Miravitlles M, Ferrara G, Lange C, et al. TB or not TB: update from the ERS Respiratory Infection Assembly 10. Eur Respir J 2010; 36: 665-670.
11. Tuberculosis Coalition for Technical Assistance. International Standards for Tuberculosis Care (ISTC), 2nd Edn. The Hague, Tuberculosis Coalition for Technical Assistance, 2009.
12. Nardell E, Dharmadhikari A. Turning off the spigot: reducing drug-resistant tuberculosis transmission in resource-limited settings. Int J Tuberc Lung Dis 2010; 14: 1233-1243.